Symbols

TNON

Tenon Medical·NASDAQ

--(--)

TNON fundamentals

TNON Q4 2025 Earnings

Tenon Medical (TNON) released its earnings on Mar 19, 2026: revenue was 1.50M (YoY +87.50%), beat estimates; EPS was -0.29 (YoY -102.75%), beat estimates.

Revenue / YoY

1.50M

+87.50%

EPS / YoY

-0.29

-102.75%

Report date

Mar 19, 2026

TNON Earnings Call Summary for Q4,2025

Revenue Surge: 2025 full-year revenue hit $3.9 million (+20% YoY), with Q4 jumping 92% to $1.5 million, driven by new physician adoption.
Gross Margin Leap: Q4 gross margin expanded to 69% from 46% YoY, reflecting operational efficiency gains.
FDA Clearance & Financing: SImmetry+ FDA approval and $4.3 million post-quarter financing bolster 2026 growth plans.
Pipeline Momentum: 29 U.S. patents and upcoming product launches position Tenon for sustained market expansion.

Earnings

EPS

Revenue

Revenue & Expenses

TNON has released its 2025 Q3 earnings report, with revenue of 1.17M, reflecting a YoY change of 32.24%, and net profit of -3.34M, showing a YoY change of -4.87%. The Sankey diagram below clearly presents TNON's revenue sources and cost distribution.

Key Indicators

Tenon Medical (TNON) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Tenon Medical (TNON)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Tenon Medical (TNON)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Tenon Medical (TNON)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown